ANTI-TNF AND ANTI-IL 17 COMBINATION THERAPY BIOMARKERS FOR INFLAMMATORY DISEASE

• 收藏
• 分享

专利权人:

AbbVie Inc.

发明人:

Jeffrey W. Voss,Carolyn A. Cuff

申请号：

US14160253

公开号：

US20140205613A1

申请日:

2014.01.21

申请国别(地区):

US

年份:

2014

代理人:

摘要：

The invention provides methods for predicting the efficacy of anti-TNF and anti-IL17 combination therapies in the treatment of a subject suffering from inflammatory disease by determining the level CXCL1 and/or CXCL5 markers in a sample derived from the subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/